RE: De-listing 19 Aug 2014 20:15
Kamel, good luck with FJET. Not a good day there today but it takes a while for a stock to turnaround after a big fundraising. I'm hopeful that the increased flights, August passenger numbers and September interims will see it starting to move up at last -- always assuming that Ebola doesn't shut the whole continent down!
Here, AIUI, the shares will still be traded for a week or so after the 11p pay-out so any movement in that period will be interesting.
I confess to having sold a chunk, partly because I reckoned I could leverage the funds better elsewhere rather than wait an indeterminate amount of time for an indeterminate second pay-out. Had the company issued an RNS to update the position wrt distribution 2 (timing, if not quantum), I could have been persuaded to let it ride. Indeed, the SP movement today suggests that someone knows more about distribution 2 than we do (hopefully not Hawkwood or any related parties but it looks like someone is confident of getting at least 3p).
Thanks for the pointer to Omega Diagnostics. Would I be right in thinking that this company poodles along taking a step forward here and a step back there and not making any money for its shareholders of the past seven years…until or unless the great white hope that is CD4 explodes into a commercial maelstrom and makes everyone rich (at last)? It might happen - but my experience in similar stocks is that they take forever to get CE and regional regulatory approvals for their miracle cures. Could CD4 still be years away from generating any revenue? And what kind of deal does Omega have with the Aussie not-for-profit inventors of the gadget? It's the kind of company I would like to give a good shaking to because they clearly have good products/treatments and they seem to have a global empire of sorts but they get excited about very small increments on fairly low base numbers. Perhaps their patents are worth more than they let on but I would really like to see them signed up to some juicy marketing/licensing deals with one or more blue chip pharmas. Maybe CD4 is the key to the door but will I live long enough to see it come to market?